200723 RESULTS

STARSHINE Trial Loses its Luster

RESEARCH NEWS 2016-09-30 Research News Topline data from one of three ongoing Phase 3 trials for idalopirdine  indicate that patients with mild to moderate Alzheimer’s disease who took the drug declined just as fast as did those on placebo. According to a press release, drug ...

New Data Reinforces Concept of Protein Propagation

CONFERENCE COVERAGE 2016-09-30 Conference Coverage Research into frontotemporal dementias has powered forward in the last few years, propelled by a new understanding of the underlying biology of this group of diseases. Nonetheless, one major roadblock is the lack of good animal models. ...

FTD Gene Hunt Turns Up CYLD and Modifying Factors

CONFERENCE COVERAGE 2016-09-30 Conference Coverage Researchers know the strongest genetic factors that cause frontotemporal dementia and amyotrophic lateral sclerosis: the genes for tau, progranulin, and the C9ORF72 repeat expansion. However, just as in the Alzheimer’s field, a ...

Tests of Social Cognition Hold Potential as FTD Outcome Measures

CONFERENCE COVERAGE 2016-09-30 Conference Coverage As frontotemporal dementia researchers gear up for trials, high up on their wish lists are better clinical outcome measures to detect change over time more sensitively than standard cognitive tests do. At the 10th International ...

Rachel Bennett

Mass General Institute for Neurodegenerative Disease
Boston, United States

Current Filters

No filters selected

Filter By

  • All
  • Past 7 Days
  • Past 30 Days
  • Past 90 Days
  • Past 12 Months
  • Specific Dates
    1. From